JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2003; 42:880-881, doi:10.1016/S0735-1097(03)00838-6
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hess, O. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hess, O. M.

Risk stratification in hypertrophic cardiomyopathy

Fact or fiction?

Otto M. Hess, MD*,*

* Swiss Cardiovascular Center, University Hospital, Bern, Switzerland



View larger version (27K):

[in a new window]
  		Figure 1 Therapeutic strategies in hypertrophic cardiomyopathy (HCM). ICD = implantable cardioverter-defibrillator; NSVT = nonsustained ventricular tachyarrhythmias.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.